Cargando…

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells

BACKGROUND: Single-cell mRNA profiling of circulating tumour cells may contribute to a better understanding of the biology of these cells and their role in the metastatic process. In addition, such analyses may reveal new knowledge about the mechanisms underlying chemotherapy resistance and tumour p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lapin, Morten, Tjensvoll, Kjersti, Oltedal, Satu, Javle, Milind, Smaaland, Rune, Gilje, Bjørnar, Nordgård, Oddmund
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452374/ https://www.ncbi.nlm.nih.gov/pubmed/28569190 http://dx.doi.org/10.1186/s12885-017-3385-3

Ejemplares similares

MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
por: Lapin, Morten, et al.
Publicado: (2016)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2018)

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
por: Edland, Karin Hestnes, et al.
Publicado: (2023)

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
por: Nordgård, Oddmund, et al.
Publicado: (2022)

Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
por: Tjensvoll, Kjersti, et al.
Publicado: (2012)

Expression profiling and intracellular localization studies of the novel Proline-, Histidine-, and Glycine-rich protein 1 suggest an essential role in gastro-intestinal epithelium and a potential clinical application in colorectal cancer diagnostics
por: Oltedal, Satu, et al.
Publicado: (2018)

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
por: Lapin, Morten, et al.
Publicado: (2023)

Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
por: Gilje, Bjørnar, et al.
Publicado: (2014)

Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients
por: Tjensvoll, Kjersti, et al.
Publicado: (2019)

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
por: Tjensvoll, Kjersti, et al.
Publicado: (2022)

The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer
por: Oltedal, Satu, et al.
Publicado: (2018)

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer
por: Lapin, Morten, et al.
Publicado: (2023)

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System
por: Nordgård, Oddmund, et al.
Publicado: (2021)

Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A
por: Berg, Marianne, et al.
Publicado: (2015)

Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer
por: Nordgård, Oddmund, et al.
Publicado: (2013)

Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma
por: Choi, Man Hung, et al.
Publicado: (2019)

Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) study
por: Søiland, Håvard, et al.
Publicado: (2022)

Platelet Microparticles Decrease Daunorubicin-Induced DNA Damage and Modulate Intrinsic Apoptosis in THP-1 Cells
por: Cacic, Daniel, et al.
Publicado: (2021)

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis
por: Cacic, Daniel, et al.
Publicado: (2021)

Genetic Heterogeneity of Single Circulating Tumour Cells in Colorectal Carcinoma
por: Hamid, Faysal Bin, et al.
Publicado: (2020)

Selective inhibition of c-Myb DNA-binding by RNA polymers
por: Nordgård, Oddmund, et al.
Publicado: (2004)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

Haplotype Analysis of Norwegian and Swedish Patients with Acute Intermittent Porphyria (AIP): Extreme Haplotype Heterogeneity for the Mutation R116W
por: Tjensvoll, Kjersti, et al.
Publicado: (2003)

Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells
por: Aya-Bonilla, Carlos Alberto, et al.
Publicado: (2020)

A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity
por: Deger, Teoman, et al.
Publicado: (2022)

Tumour Cell Heterogeneity
por: Gay, Laura, et al.
Publicado: (2016)

Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
por: Agnoletto, Chiara, et al.
Publicado: (2018)

Next-of-kin involvement in improving hospital cancer care quality and safety – a qualitative cross-case study as basis for theory development
por: Bergerød, Inger Johanne, et al.
Publicado: (2018)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway
por: Bjorland, Line Sagerup, et al.
Publicado: (2021)

Developing a Next-of-Kin Involvement Guide in Cancer Care—Results From a Consensus Process
por: Bergerød, Inger J., et al.
Publicado: (2021)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Updates in Gastrointestinal Oncology – insights from the 2008 44(th )annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2009)

Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2010)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
por: Chun, Yun Shin, et al.
Publicado: (2017)

The molecular detection of circulating tumour cells.
por: Johnson, P. W., et al.
Publicado: (1995)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients
por: Asante, Du-Bois, et al.
Publicado: (2023)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34cptn6q2jeotdqn8lnh0n2r8a